:

AURORA LANDS McLANE DRIVERLESS TRUCK DEAL

INDUSTRY DESK1 MIN READ
THU, MAY 7, 2026

■ AI-SUMMARIZED FROM 1 SOURCE ▸ TIMELINE

Aurora has secured a commercial agreement with McLane to operate autonomous trucks on routes between distribution centers across the Sun Belt. The company plans to expand operations to new routes by the end of 2026.

Aurora, a self-driving truck developer, will deploy its autonomous vehicles to handle logistics for McLane, one of North America's largest wholesale distributors. The partnership focuses on routes connecting McLane's distribution network across the U.S. Sun Belt region. The deal represents Aurora's expansion beyond pilot programs into sustained commercial operations. The company plans to scale to additional routes within the McLane network by late 2026, signaling confidence in its autonomous trucking technology. Aurora's autonomous trucks are designed to operate on highways, where the company has focused its development efforts. The McLane partnership provides a real-world testing ground for Aurora's technology while offering McLane potential cost and efficiency gains in its logistics operations. The announcement reflects growing momentum in autonomous trucking, though regulatory and safety certifications remain requirements for expanded deployment across U.S. routes.

■ SOURCES

TechCrunch

■ SUMMARY WRITTEN BY AI FROM THE LINKS ABOVE

■ MORE FROM THE STARTUPS DESK

Triomics, an AI platform automating data-heavy tasks for oncologists, secured $22M in Series B funding. The raise follows a $15M Series A in 2024.

12H AGOAI Desk

Xcena secured $135 million in Series B funding at a $570 million valuation for its MX1 chip, which handles data orchestration and KV cache management directly within memory modules.

12H AGOAI Desk

Pittsburgh-based Gray Swan, which stress-tests AI models for frontier labs, secured $40M in Series A funding at a $200M valuation. The round was co-led by Wing VC and Madrona.

20H AGOAI Desk

H1, a healthcare SaaS startup, secured $40 million in funding from CVS Health. The investment signals continued investor confidence in specialized software platforms despite AI disruption concerns.

YESTERDAYIndustry Desk

■ SUBSCRIBE TO THE DAILY BRIEF

ONE EMAIL, 5 STORIES, 06:00 UTC. UNSUBSCRIBE ANYTIME.